{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:33:46Z","timestamp":1759336426957,"version":"3.37.3"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA032290","K24 DA017072","K02 DA033139"],"award-info":[{"award-number":["R01 DA032290","K24 DA017072","K02 DA033139"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contemporaryclinicaltrials.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.cct.2019.06.012","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:55:15Z","timestamp":1561017315000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study"],"prefix":"10.1016","volume":"82","author":[{"given":"Roman","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Sibilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jude","family":"Ssenyonjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Copenhaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cct.2019.06.012_bb0005","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/QAD.0000000000001039","article-title":"HIV infection among persons who inject drugs: ending old epidemics and addressing new outbreaks","volume":"30","author":"Des Jarlais","year":"2016","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.cct.2019.06.012_bb0010","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10461-017-1988-y","article-title":"Continued transmission of HIV among young adults who inject drugs in San Francisco: still room for improvement","volume":"22","author":"Mirzazadeh","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/add.13948","article-title":"Scaling-up HCV prevention and treatment interventions in rural United States\u2014model projections for tackling an increasing epidemic","volume":"113","author":"Fraser","year":"2018","journal-title":"Addiction."},{"key":"10.1016\/j.cct.2019.06.012_bb0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s11904-018-0393-0","article-title":"Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C","volume":"15","author":"Schranz","year":"2018","journal-title":"Curr. HIV\/AIDS Rep."},{"year":"2016","series-title":"HIV surveillance report: Diagnoses of HIV infection in the United States and dependent areas, 2015","author":"CDC","key":"10.1016\/j.cct.2019.06.012_bb0025"},{"key":"10.1016\/j.cct.2019.06.012_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2019.01.020","article-title":"Comparing Canadian and United States opioid agonist therapy policies","author":"Priest","year":"2019","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.cct.2019.06.012_bb0035","doi-asserted-by":"crossref","first-page":"e1208","DOI":"10.1016\/S2214-109X(17)30373-X","article-title":"Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review","volume":"5","author":"Larney","year":"2017","journal-title":"Lancet Glob. Health"},{"year":"2018","series-title":"Medicaid Coverage of Medication-Assisted Treatment for Alcohol and Opioid Use Disorders and of Medication for the Reversal of Opioid Overdose","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.cct.2019.06.012_bb0040"},{"year":"2019","series-title":"Toward an Effective Strategy to Combat HIV, Hepatitis C and the Opioid Epidemic: Recommendations for Policy Makers","author":"The Foundation for AIDS Research","key":"10.1016\/j.cct.2019.06.012_bb0045"},{"key":"10.1016\/j.cct.2019.06.012_bb0050","doi-asserted-by":"crossref","first-page":"23","DOI":"10.15585\/mmwr.mm6701a5","article-title":"HIV infection and HIV-associated Behaviors among persons who inject drugs - 20 cities, United States, 2015","volume":"67","author":"Burnett","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0055","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of Oxymorphone--Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","article-title":"Notes from the field: HIV diagnoses among persons who inject drugs - Northeastern Massachusetts, 2015-2018","volume":"68","author":"Cranston","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0065","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1007\/s10461-018-2099-0","article-title":"Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: a pilot feasibility study","volume":"22","author":"Shrestha","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/jamainternmed.2015.4683","article-title":"Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services","volume":"176","author":"Liu","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.cct.2019.06.012_bb0075","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2352-3018(18)30008-0","article-title":"Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study","volume":"5","author":"Grinsztejn","year":"2018","journal-title":"Lancet HIV."},{"year":"2017","series-title":"US Public Health Service: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States\u20142017 Update: A Clinical Practice Guideline","author":"CDC","key":"10.1016\/j.cct.2019.06.012_bb0080"},{"key":"10.1016\/j.cct.2019.06.012_bb0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1064-1297.10.3.193","article-title":"Neurocognitive impairment associated with alcohol use disorders: implications for treatment","volume":"10","author":"Bates","year":"2002","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.cct.2019.06.012_bb0090","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","article-title":"Dose-related neurocognitive effects of marijuana use","volume":"59","author":"Bolla","year":"2002","journal-title":"Neurology."},{"key":"10.1016\/j.cct.2019.06.012_bb0095","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.neuropsychologia.2004.04.002","article-title":"Severity of neuropsychological impairment in cocaine and alcohol addiction: association with metabolism in the prefrontal cortex","volume":"42","author":"Goldstein","year":"2004","journal-title":"Neuropsychologia."},{"key":"10.1016\/j.cct.2019.06.012_bb0100","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1176\/jnp.11.3.361","article-title":"Dose-related neurobehavioral effects of chronic cocaine use","volume":"11","author":"Bolla","year":"1999","journal-title":"J. Neuropsych. Clin. Neurosci."},{"key":"10.1016\/j.cct.2019.06.012_bb0105","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.drugalcdep.2015.01.034","article-title":"Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States","volume":"149","author":"Meade","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2019.06.012_bb0110","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/ADM.0000000000000066","article-title":"Cocaine and cognition: a systematic quantitative review","volume":"8","author":"Potvin","year":"2014","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.cct.2019.06.012_bb0115","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1086\/429495","article-title":"Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature","volume":"41","author":"Gonzalez","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cct.2019.06.012_bb0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/09540121.2011.608794","article-title":"The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV\/AIDS","volume":"24","author":"Ezeabogu","year":"2012","journal-title":"AIDS Care"},{"key":"10.1016\/j.cct.2019.06.012_bb0125","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/09540121.2014.985183","article-title":"Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence","volume":"27","author":"Anderson","year":"2015","journal-title":"AIDS Care"},{"key":"10.1016\/j.cct.2019.06.012_bb0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fpubh.2014.00105","article-title":"Exploring substance use and HIV treatment factors associated with neurocognitive impairment among people living with HIV\/AIDS","volume":"2","author":"Attonito","year":"2014","journal-title":"Front. Public Health"},{"key":"10.1016\/j.cct.2019.06.012_bb0135","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s10461-011-9924-z","article-title":"Longitudinal change in cognitive function and medication adherence in HIV-infected adults","volume":"15","author":"Becker","year":"2011","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0140","first-page":"17","article-title":"Sex-related differences in self-reported neurocognitive impairment among high-risk cocaine users in methadone maintenance treatment program","volume":"9","author":"Shrestha","year":"2015","journal-title":"Substance Abuse"},{"key":"10.1016\/j.cct.2019.06.012_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1037\/0893-164X.20.3.241","article-title":"Cognitive impairment influences drinking outcome by altering therapeutic mechanisms of change","volume":"20","author":"Bates","year":"2006","journal-title":"Psychol. Addict. Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0150","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00213-006-0632-8","article-title":"Profile of executive deficits in cocaine and heroin polysubstance users: common and differential effects on separate executive components","volume":"190","author":"Verdejo-Garcia","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.cct.2019.06.012_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.drugalcdep.2007.02.015","article-title":"Neurocognitive characterizations of Russian heroin addicts without a significant history of other drug use","volume":"90","author":"Fishbein","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2019.06.012_bb0160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/08897077.2014.954027","article-title":"Working memory impairment in cannabis- and opioid-dependent adolescents","volume":"35","author":"Vo","year":"2014","journal-title":"Subst. Abus."},{"key":"10.1016\/j.cct.2019.06.012_bb0165","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1007\/s10461-016-1394-x","article-title":"Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction Behaviors among drug users in treatment","volume":"20","author":"Huedo-Medina","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","article-title":"BRIEF REPORT: methadone treatment of injecting opioid users for prevention of HIV infection","volume":"21","author":"Gowing","year":"2006","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.cct.2019.06.012_bb0175","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.drugalcdep.2013.06.024","article-title":"Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior: Outcomes of a randomized trial","volume":"133","author":"Otiashvili","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2019.06.012_bb0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/QAI.0000000000000165","article-title":"HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial","volume":"66","author":"Woody","year":"2014","journal-title":"J. Acquired Immune Deficiency Syndromes (1999)"},{"key":"10.1016\/j.cct.2019.06.012_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5945","article-title":"Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis","volume":"345","author":"MacArthur","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.cct.2019.06.012_bb0190","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11904-014-0228-6","article-title":"Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches","volume":"11","author":"Brown","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-018-2099-0","article-title":"Integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and reduce HIV risk in people who use drugs: a pilot feasibility study","author":"Shrestha","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00561","article-title":"Developing an integrated, brief Biobehavioral HIV prevention intervention for high-risk drug users in treatment: the process and outcome of formative research","volume":"8","author":"Shrestha","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cct.2019.06.012_bb0205","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s10461-013-0539-4","article-title":"A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment","volume":"17","author":"Copenhaver","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0210","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact","volume":"50","author":"Curran","year":"2012","journal-title":"Med. Care"},{"year":"2010","series-title":"Applied Methods of Cost-Effectiveness Analysis in Healthcare","author":"Gray","key":"10.1016\/j.cct.2019.06.012_bb0215"},{"key":"10.1016\/j.cct.2019.06.012_bb0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jsat.2016.01.002","article-title":"An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment among participants enrolled in methadone maintenance therapy","volume":"63","author":"Copenhaver","year":"2015","journal-title":"J. Substance Abuse Treat."},{"key":"10.1016\/j.cct.2019.06.012_bb0225","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1007\/s10461-016-1637-x","article-title":"Examining the acceptability of mHealth technology in HIV prevention among high-risk drug users in treatment","volume":"21","author":"Shrestha","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.12.023","article-title":"Correlates of willingness to use pre-exposure prophylaxis (PrEP) and the likelihood of practicing safer drug- and sex-related risk behaviors while on PrEP among high-risk drug users in treatment","volume":"173","author":"Shrestha","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.cct.2019.06.012_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0197-2456(88)90048-7","article-title":"Properties of the urn randomization in clinical trials","volume":"9","author":"Wei","year":"1988","journal-title":"Control. Clin. Trials"},{"key":"10.1016\/j.cct.2019.06.012_bb0240","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/biomet\/58.3.403","article-title":"Forcing a sequential experiment to be balanced","volume":"58","author":"Efron","year":"1971","journal-title":"Biometrika."},{"key":"10.1016\/j.cct.2019.06.012_bb0245","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1037\/0033-2909.111.3.455","article-title":"Changing AIDS-risk behavior","volume":"111","author":"Fisher","year":"1992","journal-title":"Psychol. Bull."},{"year":"2002","series-title":"Motivational interviewing: Preparing people for change","author":"Miller","key":"10.1016\/j.cct.2019.06.012_bb0250"},{"key":"10.1016\/j.cct.2019.06.012_bb0255","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1089\/apc.1991.5.255","article-title":"Support groups for hospitalized AIDS patients","volume":"5","author":"Buck","year":"1991","journal-title":"AIDS Patient Care."},{"key":"10.1016\/j.cct.2019.06.012_bb0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/09540129650125498","article-title":"A community support group for HIV-seropositive drug users: is attendance associated with reductions in risk behaviour?","volume":"8","author":"Greenberg","year":"1996","journal-title":"AIDS Care"},{"key":"10.1016\/j.cct.2019.06.012_bb0265","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/00224498909551534","article-title":"A support Group for Individuals Recently Testing HIV positive: a psycho-educational group model","volume":"26","author":"Coleman","year":"1989","journal-title":"J. Sex Res."},{"key":"10.1016\/j.cct.2019.06.012_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/00952990601087463","article-title":"Successfully integrating an HIV risk reduction intervention into a community-based substance abuse treatment program","volume":"33","author":"Copenhaver","year":"2007","journal-title":"Am. J. Drug Alcohol Abuse."},{"key":"10.1016\/j.cct.2019.06.012_bb0275","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/08897077.2011.540466","article-title":"Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users","author":"Copenhaver","year":"2011","journal-title":"Subst Abus. England"},{"key":"10.1016\/j.cct.2019.06.012_bb0280","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1007\/s10461-013-0539-4","article-title":"A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment","volume":"17","author":"Copenhaver","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0285","first-page":"276","article-title":"Improving representation of linguistic minorities in health surveys","volume":"111","author":"Turner","year":"1996","journal-title":"Public Health Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0290","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1126\/science.280.5365.867","article-title":"Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology","volume":"280","author":"Turner","year":"1998","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.cct.2019.06.012_bb0295","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/jwh.1997.6.209","article-title":"Psychological and social factors associated with histories of risk for human immunodeficiency virus infection among African-American inner-city women","volume":"6","author":"Kalichman","year":"1997","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.cct.2019.06.012_bb0300","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpba.2013.08.033","article-title":"Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS\/MS","volume":"88","author":"Zheng","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cct.2019.06.012_bb0305","doi-asserted-by":"crossref","DOI":"10.1310\/JFXH-G3X2-EYM6-D6UG","article-title":"Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale","volume":"5","author":"Giordano","year":"2004","journal-title":"HIV Clin. Trials."},{"key":"10.1016\/j.cct.2019.06.012_bb0310","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/107319119400100407","article-title":"Reliability of drug users\u2019 self-reported HIV risk Behaviors and validity of self-reported recent drug use","volume":"1","author":"Dowling-Guyer","year":"1994","journal-title":"Assessment."},{"issue":"Suppl. 2","key":"10.1016\/j.cct.2019.06.012_bb0315","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/01.qai.0000140605.51640.5c","article-title":"Clinician-initiated HIV risk reduction intervention for HIV-positive persons: formative research, acceptability, and fidelity of the options project","volume":"37","author":"Fisher","year":"2004","journal-title":"J. Acquired Immune Deficiency Syndromes (1999)"},{"key":"10.1016\/j.cct.2019.06.012_bb0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.qai.0000159666.95455.d2","article-title":"HIV drug resistance and HIV transmission risk behaviors among active injection drug users","volume":"40","author":"Kozal","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"year":"1995","series-title":"Reliability in Project Match: A Preliminary Report on the Cross-Reliability Study","author":"Del Boca","key":"10.1016\/j.cct.2019.06.012_bb0325"},{"key":"10.1016\/j.cct.2019.06.012_bb0330","first-page":"1","article-title":"Willingness to use pre-exposure prophylaxis (PrEP): an empirical test of the information-motivation-Behavioral skills (IMB) model among high-risk drug users in treatment","author":"Shrestha","year":"2016","journal-title":"AIDS Behav."},{"key":"10.1016\/j.cct.2019.06.012_bb0335","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0740-5472(03)00159-4","article-title":"Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy","volume":"26","author":"Avants","year":"2004","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.cct.2019.06.012_bb0340","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","article-title":"The validity of the Mini international neuropsychiatric interview (MINI) according to the SCID-P and its reliability","volume":"12","author":"Sheehan","year":"1997","journal-title":"Eur. Psychiatr."},{"key":"10.1016\/j.cct.2019.06.012_bb0345","article-title":"The CES-D scale: a self report depression scale for research in the general population","volume":"3","author":"Radloff","year":"1977","journal-title":"Appl. Psychol. Meas."},{"year":"2001","series-title":"The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care","author":"Babor","key":"10.1016\/j.cct.2019.06.012_bb0350"},{"key":"10.1016\/j.cct.2019.06.012_bb0355","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey","volume":"32","author":"Sherbourne","year":"1991","journal-title":"Social Sci. Med. (1982)"},{"key":"10.1016\/j.cct.2019.06.012_bb0360","first-page":"1091","article-title":"Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships","volume":"67","author":"Anderson","year":"1990","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.cct.2019.06.012_bb0365","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S1473-3099(14)70847-3","article-title":"Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study","volume":"14","author":"Grant","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.cct.2019.06.012_bb0370","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/aid.2012.0089","article-title":"Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure","volume":"29","author":"Castillo-Mancilla","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"year":"1991","series-title":"Design and Analysis: A Researcher\u2019s Handbook","author":"Keppel","key":"10.1016\/j.cct.2019.06.012_bb0375"},{"year":"2012","series-title":"Applied Multivariate Statistics for the Social Sciences","author":"Stevens","key":"10.1016\/j.cct.2019.06.012_bb0380"},{"key":"10.1016\/j.cct.2019.06.012_bb0385","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/00220973.1971.11011304","article-title":"The effect of experimental mortality on the internal and external validity of the randomized comparative experiment","volume":"40","author":"Jurs","year":"1971","journal-title":"J. Exp. Educ."},{"key":"10.1016\/j.cct.2019.06.012_bb0390","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1037\/0033-2909.118.3.392","article-title":"Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models","volume":"118","author":"Gardner","year":"1995","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.cct.2019.06.012_bb0395","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpba.2016.01.038","article-title":"Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots","volume":"122","author":"Zheng","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.cct.2019.06.012_bb0400","doi-asserted-by":"crossref","first-page":"6692","DOI":"10.1128\/AAC.01017-16","article-title":"Emtricitabine-triphosphate in dried blood spots as a marker of recent dosing","volume":"60","author":"Castillo-Mancilla","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"year":"2012","series-title":"Mplus User\u2019s Guide","author":"Muth\u00e9n","key":"10.1016\/j.cct.2019.06.012_bb0405"},{"issue":"5","key":"10.1016\/j.cct.2019.06.012_bb0410","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v059.i05","article-title":"Mediation: R package for causal mediation analysis","volume":"1","author":"Tingley","year":"2014","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.cct.2019.06.012_bb0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1037\/a0020761","article-title":"A general approach to causal mediation analysis","volume":"15","author":"Imai","year":"2010","journal-title":"Psychol. Methods"},{"year":"2004","series-title":"Multiple Imputation for Nonresponse in Surveys","author":"Rubin","key":"10.1016\/j.cct.2019.06.012_bb0420"}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714419300515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714419300515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T10:44:08Z","timestamp":1569235448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714419300515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":84,"alternative-id":["S1551714419300515"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2019.06.012","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2019.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}